Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight☆
References (37)
- et al.
Compliance with maintenance medication in first episode schizophrenia
Schizophr Res
(1997) - et al.
Insight in clinical psychiatry revisited
Compr Psychiatry
(1995) Overview: Maintenance therapy in psychiatry. I. Schizophrenia
Am J Psychiatry
(1975)- et al.
Predicting medication compliance in a psychotic population
J Nerv Ment Dis
(1993) Will the new antipsychotics improve the treatment of schizophrenia?
Br Med J
(1993)- et al.
A prospective, multicenter study of patients' refusal of antipsychotic medication
Arch Gen Psychiatry
(1990) - et al.
Surreptitious noncompliance with oral fluphenazine in a voluntary inpatient population
Arch Gen Psychiatry
(1990) - et al.
Do psychiatric outpatients take their drugs?
Br Med J
(1965) - et al.
Rating of medication influences (ROMI) scale in schizophrenia
Schizophr Bull
(1994) - et al.
A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity
Psychol Med
(1983)
A two-year prospective study of treatment compliance in patients with schizophrenia
Psychol Med
Insight and psychosis
Br J Psychiatry
Awareness of illness in schizophrenia
Schizophr Bull
Lack of insight in schizophrenia
Schizophr Bull
Insight and adherence to medication in chronic schizophrenics
J Clin Psychiatry
A comparison of patients who refuse and consent to neuroleptic treatment
Am J Psychiatry
Clinical symptomatology and drug compliance in schizophrenic patients
Acta Psychiatr Scand
Relationship between insight, educational background and cognition in schizophrenia
Br J Psychiatry
Cited by (96)
Cultural translation and Tunisian validation of the Drug Attitude Inventory (DAI-30) in outpatients with schizophrenia
2015, Comprehensive PsychiatryCompliance and schizophrenia: The predictive potential of insight into illness, symptoms, and side effects
2010, Comprehensive PsychiatryCitation Excerpt :One explanation for the discrepancy between these studies may lie in differences in the cognitive impairment measures used and study designs. Antipsychotic side effects could influence noncompliance and reluctance to accept treatment of schizophrenia [32-34]. Available research suggests that extrapyramidal side effects, and the related features of neuroleptic dysphoria, sedation, weight gain, and sexual dysfunction may influence medication compliance [32-34].
The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health
2009, Comprehensive PsychiatryCitation Excerpt :A separate topic assessment of TR could provide an independent outcome measure that is relevant to adherence. It could also be of interest to analyze correlations between TR and other predictive variables of adherence such as insight [25], attitudes toward neuroleptics [26], or subjective well-being. Our results must be cautiously interpreted considering the fact that the study was carried out on an inpatient population.
Attitudes toward medication in inpatients with schizophrenia: A cluster analytic approach
2008, Psychiatry ResearchCitation Excerpt :The positive attitude items that more frequently had scores of ‘3’ suggest that patients with positive ATM are driven by individual motivations (perceived benefits and fear of rehospitalization), personality traits such as sensitivity to authoritative pressures and a positive family climate about medication. Denial of illness represents a major reason for negative attitudes; lack of insight may be associated with poor compliance (Kamali et al., 2001; Adewuya et al., 2006), but this is not a consistent finding (Garavan et al., 1995). Another prominent reason for negative ATM was opposition to medication.
- ☆
Supported by the Theodore and Vada Stanley Research Foundation (USA) and the St. John of God Order.